GuoLine Advisory’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $29.5M | Hold |
426,700
| – | – | 3.12% | 16 |
|
|
2025
Q1 | $29.6M | Buy |
426,700
+80,200
| +23% | +$5.57M | 3.14% | 16 |
|
|
2024
Q4 | $29.8M | Buy |
346,500
+58,900
| +20% | +$5.07M | 3.08% | 17 |
|
|
2024
Q3 | $34.2M | Hold |
287,600
| – | – | 3.49% | 14 |
|
|
2024
Q2 | $41.1M | Hold |
287,600
| – | – | 4.38% | 9 |
|
|
2024
Q1 | $36.9M | Buy |
287,600
+110,000
| +62% | +$14.1M | 4.5% | 11 |
|
|
2023
Q4 | $18.4M | Buy |
+177,600
| New | +$18.4M | 2.91% | 13 |
|